Hansmann ML - Search Results

1

Clinical trials with an anti-CD25 ricin A-chain experimental and immunotoxin (RFT5-SMPT-dgA) in Hodgkin's lymphoma.

Schnell R, Vitetta E, Schindler J, Barth S, Winkler U, Borchmann P, Hansmann ML, Diehl V, Ghetie V, Engert A. Schnell R, et al. Among authors: hansmann ml. Leuk Lymphoma. 1998 Aug;30(5-6):525-37. doi: 10.3109/10428199809057565. Leuk Lymphoma. 1998. PMID: 9711915 Clinical Trial.

2

A phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin's lymphoma.

Engert A, Diehl V, Schnell R, Radszuhn A, Hatwig MT, Drillich S, Schön G, Bohlen H, Tesch H, Hansmann ML, Barth S, Schindler J, Ghetie V, Uhr J, Vitetta E. Engert A, et al. Among authors: hansmann ml. Blood. 1997 Jan 15;89(2):403-10. Blood. 1997. PMID: 9002941 Free article. Clinical Trial.

3

Antidisialoganglioside ricin A-chain immunotoxins show potent antitumor effects in vitro and in a disseminated human neuroblastoma severe combined immunodeficiency mouse model.

Gottstein C, Schön G, Tawadros S, Kube D, Wargalla-Plate UC, Hansmann ML, Wacker HH, Berthold F, Diehl V, Engert A. Gottstein C, et al. Among authors: hansmann ml. Cancer Res. 1994 Dec 1;54(23):6186-93. Cancer Res. 1994. PMID: 7954465

4

Potent anti-tumor effects of an anti-CD24 ricin A-chain immunotoxin in vitro and in a disseminated human Burkitt's lymphoma model in SCID mice.

Schnell R, Katouzi AA, Linnartz C, Schoen G, Drillich S, Hansmann ML, Schiefer D, Barth S, Zangemeister-Wittke U, Stahel RA, Diehl V, Engert A. Schnell R, et al. Among authors: hansmann ml. Int J Cancer. 1996 May 16;66(4):526-31. doi: 10.1002/(SICI)1097-0215(19960516)66:4<526::AID-IJC17>3.0.CO;2-5. Int J Cancer. 1996. PMID: 8635869 Free article.

5

Lymphocyte predominant Hodgkin's disease--a workshop report. European Task Force on Lymphoma.

Sextro M, Diehl V, Franklin J, Hansmann ML, Anagnostopoulos I, Marafioti T, Stein H. Sextro M, et al. Among authors: hansmann ml. Ann Oncol. 1996;7 Suppl 4:61-5. doi: 10.1093/annonc/7.suppl_4.s61. Ann Oncol. 1996. PMID: 8836412 Review.

6

Successful treatment of disseminated human Hodgkin's disease in SCID mice with deglycosylated ricin A-chain immunotoxins.

Winkler U, Gottstein C, Schön G, Kapp U, Wolf J, Hansmann ML, Bohlen H, Thorpe P, Diehl V, Engert A. Winkler U, et al. Among authors: hansmann ml. Blood. 1994 Jan 15;83(2):466-75. Blood. 1994. PMID: 8286745 Free article.

7

Hodgkin lymphoma.

Küppers R, Engert A, Hansmann ML. Küppers R, et al. Among authors: hansmann ml. J Clin Invest. 2012 Oct;122(10):3439-47. doi: 10.1172/JCI61245. Epub 2012 Oct 1. J Clin Invest. 2012. PMID: 23023715 Free PMC article. Review.

8

Rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: long-term follow-up of a phase 2 study from the German Hodgkin Study Group.

Eichenauer DA, Plütschow A, Fuchs M, Hartmann S, Hansmann ML, Böll B, von Tresckow B, Borchmann P, Engert A. Eichenauer DA, et al. Among authors: hansmann ml. Leukemia. 2020 Mar;34(3):953-956. doi: 10.1038/s41375-019-0609-3. Epub 2019 Oct 21. Leukemia. 2020. PMID: 31636342 Clinical Trial. No abstract available.

9

Lymphocyte predominant Hodgkin's disease: pathology and clinical implication.

Franklin J, Tesch H, Hansmann ML, Diehl V. Franklin J, et al. Among authors: hansmann ml. Ann Oncol. 1998;9 Suppl 5:S39-44. doi: 10.1093/annonc/9.suppl_5.s39. Ann Oncol. 1998. PMID: 9926236 Review.

10

[Immune dysregulation and malignant lymphoma].

Tesch H, Doerfler W, Engert A, Hansmann M, Radbruch A, Rajewsky K, Wolf J, Diehl V. Tesch H, et al. Internist (Berl). 1995 Apr;36(4):367-71. Internist (Berl). 1995. PMID: 7775086 Review. German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

489 results

Search Page